Eli Lilly launches new pet medicine group
ORLANDO, Fla., Jan. 15 (UPI) -- Florida-based pharmaceutical giant Eli Lilly launched a new business group focusing on pet health products Monday.
Many of the compounds already patented by the company for use in humans will also be valuable to veterinarians, the company said in a statement, and over the past seven years those compounds have been carefully evaluated for use in animal treatments. The company's first pet products are expected to be introduced within the year, pending approval by the Food and Drug Administration.
Veterinarians will benefit from the company's experience in technical and case-managment support, a company spokesman said, and both pets and their owners will benefit from improved health."
All the puppies are inattentive and hyperactive in the waiting room and are suffering from ADHD (Attention Deficit Hyperactive Doggieness). Our drug STRATTERA will calm it down.
The dogs you have in the vetinary post op cages are clearly, as in the Dogged Statistical Manual IV, suffering from major dogpressive disorder with schizoaffective borderline features. Prozac and Zyprexa are the best on the market."